Edwards Lifesciences Corp. (EW) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $92.21 +0.96%
EPS Growth %: +10.4%
Financial Fact:
Income before provision for income taxes: 185.2M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +10.4%
Financial Fact:
Income before provision for income taxes: 185.2M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $430.2 million versus the consensus estimate of $446.94 million.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
- Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
